The RS-001 readout was the closest we have had to an unambiguous readout from Anavex.
You clearly are unable to or paid not to see there have been issue with Anavex readouts.
The PDD readout was not unambiguous, neither was the AVATAR and P2b/3 AD trial readouts. The latter one goes on being unclear and with no reliably executed actions per company's own statements and expectations. Instead we get drip/drap piecemeal updates and new strategy statements, such as no parallel confirmatory trial being initiated because Anavex have heard perhaps the OLE study can take its place.
How much are they paying you to be so blind and an Missling Apologist?